193 related articles for article (PubMed ID: 21592456)
1. Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease.
Deppen S; Putnam JB; Andrade G; Speroff T; Nesbitt JC; Lambright ES; Massion PP; Walker R; Grogan EL
Ann Thorac Surg; 2011 Aug; 92(2):428-32; discussion 433. PubMed ID: 21592456
[TBL] [Abstract][Full Text] [Related]
2. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
Bryant AS; Cerfolio RJ
Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
[TBL] [Abstract][Full Text] [Related]
3. Solitary pulmonary nodule evaluation in regions endemic for infectious diseases: Do regional variations impact the effectiveness of fluorodeoxyglucose positron emission tomography/computed tomography.
Purandare NC; Pramesh CS; Agarwal JP; Agrawal A; Shah S; Prabhash K; Karimundackal G; Jiwnani S; Tandon S; Rangarajan V
Indian J Cancer; 2017; 54(1):271-275. PubMed ID: 29199704
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of fluorodeoxyglucose-positron emission tomography within the clinical practice of the American College of Surgeons Oncology Group Z4031 trial to diagnose clinical stage I non-small cell lung cancer.
Grogan EL; Deppen SA; Ballman KV; Andrade GM; Verdial FC; Aldrich MC; Chen CL; Decker PA; Harpole DH; Cerfolio RJ; Keenan RJ; Jones DR; D'Amico TA; Shrager JB; Meyers BF; Putnam JB
Ann Thorac Surg; 2014 Apr; 97(4):1142-8. PubMed ID: 24576597
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis.
Deppen SA; Blume JD; Kensinger CD; Morgan AM; Aldrich MC; Massion PP; Walker RC; McPheeters ML; Putnam JB; Grogan EL
JAMA; 2014 Sep; 312(12):1227-36. PubMed ID: 25247519
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.
Dewan NA; Gupta NC; Redepenning LS; Phalen JJ; Frick MP
Chest; 1993 Oct; 104(4):997-1002. PubMed ID: 8404239
[TBL] [Abstract][Full Text] [Related]
7. Improvement in sensitivity with delayed imaging of pulmonary lesions with FDG-PET.
Núñez R; Kalapparambath A; Varela J
Rev Esp Med Nucl; 2007; 26(4):196-207. PubMed ID: 17662186
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
9. Dual-time-point
Huang YE; Huang YJ; Ko M; Hsu CC; Chen CF
Ann Nucl Med; 2016 Nov; 30(9):652-658. PubMed ID: 27492555
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ
AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography in the evaluation of pulmonary nodules among patients living in a coccidioidal endemic region.
Reyes N; Onadeko OO; Luraschi-Monjagatta Mdel C; Knox KS; Rennels MA; Walsh TK; Ampel NM
Lung; 2014 Aug; 192(4):589-93. PubMed ID: 24801058
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
Lee ST; Berlangieri SU; Poon AM; Mitchell P; Pathmaraj K; Tabone K; Byrne AJ; O'Keefe GJ; Knight SR; Clarke CP; Scott AM
Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules.
Maiga AW; Deppen SA; Mercaldo SF; Blume JD; Montgomery C; Vaszar LT; Williamson C; Isbell JM; Rickman OB; Pinkerman R; Lambright ES; Nesbitt JC; Grogan EL
JAMA Surg; 2018 Apr; 153(4):329-334. PubMed ID: 29117314
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K
J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of contrast-enhanced computed tomography and positron emission tomography with 18-FDG in identifying malignant solitary pulmonary nodules.
Dabrowska M; Krenke R; Korczynski P; Maskey-Warzechowska M; Zukowska M; Kunikowska J; Orłowski T; Chazan R
Medicine (Baltimore); 2015 Apr; 94(15):e666. PubMed ID: 25881842
[TBL] [Abstract][Full Text] [Related]
16. Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions.
Gupta N; Gill H; Graeber G; Bishop H; Hurst J; Stephens T
Chest; 1998 Oct; 114(4):1105-11. PubMed ID: 9792584
[TBL] [Abstract][Full Text] [Related]
17. [Positron emission tomography using 18-FDG-PET in radiologically indeterminate pulmonary lesions].
Ruiz-Hernández G; de Juan R; Samanes A; Verea H; Peñas JM; Veres A; Lapeña L; Montz R; Carreras JL
An Med Interna; 2004 Jan; 21(1):12-6. PubMed ID: 15195479
[TBL] [Abstract][Full Text] [Related]
18. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK
Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
[TBL] [Abstract][Full Text] [Related]
19. PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma.
Poncelet AJ; Lonneux M; Coche E; Weynand B; Noirhomme P;
Eur J Cardiothorac Surg; 2001 Sep; 20(3):468-74; discussion 474-5. PubMed ID: 11509265
[TBL] [Abstract][Full Text] [Related]
20. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S
Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
